In our study, through pull-down assays and treatment with an HSP90 inhibitor, we proved that the SRC kinases LCK and LYN were both clients of HSP90, in T-ALL and B-ALL cells, respectively. Here, LYN is linked to acute lymphoblastic leukemia.